Exact Sciences Announces Fourth Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- S&P 500, Nasdaq eye tepid open as Middle East tensions weigh
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Exact Sciences (EXAS) Misses Q4 EPS by 24c, Revenue Beats, Offers Guidance
February 22, 2022 4:11 PM ESTExact Sciences (NASDAQ: EXAS) reported Q4 EPS of ($1.28), $0.24 worse than the analyst estimate of ($1.04). Revenue for the quarter came in at $473.8 million versus the consensus estimate of $449 million.
GUIDANCE:
Exact Sciences sees FY2022 revenue of $1.975-2.027 billion, versus the consensus of $1.99... More
